This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bikenbiomics Co., Ltd., Osaka University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020
Title: Tadayasu Ohkubo: Innovator in Peptide Research
Introduction
Tadayasu Ohkubo is a notable inventor based in Suita, Japan. He has made significant contributions to the field of peptide research, particularly in the development of peptides that inhibit the colonization of pathogenic bacteria in digestive organs. His innovative work has implications for improving health and preventing infections.
Latest Patents
Ohkubo holds a patent titled "Peptide inhibiting colonization by pathogenic bacteria, and colonization inhibitor including same." This patent describes a peptide capable of preventing pathogenic bacteria from colonizing in digestive organs. The peptide comprises a first domain with an amino acid sequence that binds to a minor pilin of IVb fimbriae, and a second domain that allows for multimerization. The second domain is connected to the first domain via a linker sequence. This invention represents a significant advancement in the fight against bacterial infections.
Career Highlights
Throughout his career, Tadayasu Ohkubo has worked with esteemed institutions, including Osaka University and Bikenbiomics Co., Ltd. His research has focused on the development of innovative solutions to combat bacterial colonization, showcasing his dedication to advancing medical science.
Collaborations
Ohkubo has collaborated with notable colleagues, including Yuji Kobayashi and Takahiro Maruno. These partnerships have contributed to the success of his research and the development of his patented technologies.
Conclusion
Tadayasu Ohkubo is a distinguished inventor whose work in peptide research has the potential to significantly impact health care. His innovative patent and collaborations highlight his commitment to advancing scientific knowledge and improving public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile